March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who received ...

The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy (DAPT) for either six months or at least 12 months after receiving a drug-eluting stent. Patients who were given DAPT for only six months, however, had more than double the risk of a heart attack compared with those treated for at least 12 months, according to research presented at the American College of Cardiology’s (ACC) 67th Annual Scientific Session, March 10-12 in Orlando, Fla.

March 15, 2018 – A newly-designed wristband and corresponding app that works with a smartwatch can accurately display ...

March 15, 2018 — Women with normal blood pressure during pregnancy and who breastfed their babies for at least six ...

March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...